View Exam | PowerPak

1. An example of a concordant comorbidity in patients with type 2 diabetes is:

A. Hepatitis C B. Chronic Kidney Disease C. Cognitive Impairment D. Asthma E. Unsure

2. Pharmacologic treatments used in which of the following common diabetes comorbidities can contribute to risk of type 2 diabetes or worsening of type 2 diabetes?

A. Nonalcoholic fatty liver disease B. Cognitive impairment C. Gastroparesis D. Schizophrenia E. Unsure

3. For patients with HIV, which of the following recommendation is important for patients in terms of diabetes?

A. A1C is the preferred measurement over self-monitoring of blood glucose B. Self-monitoring of blood glucose may be preferred over A1C C. GLP-1 receptor agonists may have higher risk of infection in patients with HIV D. Older generations of drugs to treat HIV have a lower risk of diabetes E. Unsure

4. How are psychosocial disorders related to type 2 diabetes?

A. There is a higher prevalence of depression but not anxiety with type 2 diabetes B. Treatments used for type 2 diabetes management can increase the risk of depression in patients C. Psychosocial disorders have no direct relationship to type 2 diabetes D. Poor diet and sedentary lifestyle common in patients with psychosocial disorders contributes to diabetes risk E. Unsure

5. Treatment decisions should consider the risk of pancreatitis when prescribing _______________?

A. SGLT2 inhibitors B. Insulin C. Sulfonylureas D. GLP-1 receptor agonists E. Unsure

6. Which items should be included in every follow-up visit for patients with diabetes based on ADA recommendations?

A. History of hypoglycemia and sleep B. Technology use and current medications C. Weight and liver function D. Lipid profile and serum creatinine E. Unsure

7. Which laboratory evaluation(s) should be performed every 3 months in patients with type 2 diabetes?

A. A1C B. A1C and lipid panel C. eGFR D. A1C and eGFR E. Unsure

8. Cardiovascular outcomes trials of DPP-4 inhibitors have demonstrated?

A. Benefit in cardiovascular disease B. Cardiovascular safety C. Increased risk of morbidity D. Inferiority to glimepiride E. Unsure

9. ASCVD benefit as demonstrates for which agents for type 2 diabetes?

A. Exenatide and empagliflozin B. Canagliflozin and dulaglutide C. Empagliflozin and oral semaglutide D. Dapagliflozin and liraglutide E. Unsure

10. In patients with heart failure or chronic kidney disease, or at high risk, what class is recommended first-line by the ADA in appropriate patients?

A. TZDs B. Basal insulin C. SGLT2 inhibitors D. DPP-4 inhibitors E. Unsure

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. An example of a concordant comorbidity in patients with type 2 diabetes is:

2. Pharmacologic treatments used in which of the following common diabetes comorbidities can contribute to risk of type 2 diabetes or worsening of type 2 diabetes?

3. For patients with HIV, which of the following recommendation is important for patients in terms of diabetes?

4. How are psychosocial disorders related to type 2 diabetes?

5. Treatment decisions should consider the risk of pancreatitis when prescribing _______________?

6. Which items should be included in every follow-up visit for patients with diabetes based on ADA recommendations?

7. Which laboratory evaluation(s) should be performed every 3 months in patients with type 2 diabetes?

8. Cardiovascular outcomes trials of DPP-4 inhibitors have demonstrated?

9. ASCVD benefit as demonstrates for which agents for type 2 diabetes?

10. In patients with heart failure or chronic kidney disease, or at high risk, what class is recommended first-line by the ADA in appropriate patients?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. An example of a concordant comorbidity in patients with type 2 diabetes is:

2. Pharmacologic treatments used in which of the following common diabetes comorbidities can contribute to risk of type 2 diabetes or worsening of type 2 diabetes?

3. For patients with HIV, which of the following recommendation is important for patients in terms of diabetes?

4. How are psychosocial disorders related to type 2 diabetes?

5. Treatment decisions should consider the risk of pancreatitis when prescribing _______________?

6. Which items should be included in every follow-up visit for patients with diabetes based on ADA recommendations?

7. Which laboratory evaluation(s) should be performed every 3 months in patients with type 2 diabetes?

8. Cardiovascular outcomes trials of DPP-4 inhibitors have demonstrated?

9. ASCVD benefit as demonstrates for which agents for type 2 diabetes?

10. In patients with heart failure or chronic kidney disease, or at high risk, what class is recommended first-line by the ADA in appropriate patients?

« Return to Activity

Customers who Purchased
this Activity also Purchased